← Eichor
Study identifier: NCT07182981 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Patients Diagnosed With Scleroderma and Their Chewing and Swallowing Performance

Condition: Systemic Sclerosis (SSc) · Scleroderma · Scleroderma (Limited and Diffuse)  ·  Sponsor: Hacettepe University

PhaseN/A
Planned participants50
Who can joinAll sexes, 7 Years to no upper limit
Healthy volunteersNo

About this study

It is recommended to focus on the physical functionality, chewing, and swallowing performance of individuals diagnosed with scleroderma. There is a need to address children and adults diagnosed with scleroderma comprehensively and to evaluate them on a biopsychosocial basis to support their disease management. The aim was to assess the biopsychosocial characteristics of both children and adults diagnosed with scleroderma and to examine their chewing and swallowing performance. Additionally, this study aims to identify effective scales that can be used in future research to assess chewing and swallowing in individuals diagnosed with scleroderma.

This description comes directly from the study's public registry record.

Talk to the study team

Orkun Tüfekçi, PT, PhD(c)  ·  5319502648  ·  orkuntf@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Hacettepe UniversityÇankaya, Ankara, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07182981